Financhill
Back

Akebia Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Buy
66

AKBA
Akebia Therapeutics

Last Price:
1.86
Seasonality Move:
32.87%
Sell
37

LLY
Eli Lilly and

Last Price:
806.37
Seasonality Move:
3.94%
Buy
66
Akebia Therapeutics (AKBA) is a Buy

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.86. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy, Sell or Hold?

  • The current Eli Lilly and [LLY] share price is $806.06. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

  • The Eli Lilly and share price today is $806.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing slight buying pressure.

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 78.3 Buy
Chaikin Money Flow: 2495662 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.29 - 1.67) Buy
Bollinger Bands (100): (1.12 - 1.54) Buy

LLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -23.59 Sell
Relative Strength Index (14 RSI): 23.64 Sell
Chaikin Money Flow: 1666322 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (852.08 - 924.68) Sell
Bollinger Bands (100): (851.07 - 940.27) Sell

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.71 Buy
20-day SMA: 1.52 Buy
50-day SMA: 1.44 Buy
200-day SMA: 1.39 Buy
8-day EMA: 1.72 Buy
20-day EMA: 1.58 Buy
50-day EMA: 1.47 Buy
200-day EMA: 1.34 Buy

LLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 849.95 Sell
20-day SMA: 888.14 Sell
50-day SMA: 905.66 Sell
200-day SMA: 827.18 Sell
8-day EMA: 840.9 Sell
20-day EMA: 871.82 Sell
50-day EMA: 888.86 Sell
200-day EMA: 815.89 Sell

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.91 per share, and an increase next year of $9.61 per share.

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):